Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to hiv infection among high-risk HIV-i-seronegative hemophiliacs

Michael M. Lederman, J. Brooks Jackson, Barbara L. Kroner, Gilbert C. White, M. Elaine Eyster, Louis M. Aledort, Margaret W. Hilgartner, Craig M. Kessler, Alan R. Cohen, Kevin P. Kiger, James J. Goedert

    Research output: Contribution to journalArticle

    13 Scopus citations

    Abstract

    Blood samples were obtained from 16 hemophiliacs who had a 50%-94% defined risk of human immunodeficiency virus (HIV) type 1 infection on the basis of treatment history and from 14 controls not at risk for HIV infection. HIV-1 was not detected in any of 12 patient samples by cocultivation nor in 14 patient samples by the polymerase chain reaction. Peripheral blood cells from 7 seronegative hemophiliacs at highest risk of seroconversion (94%) were less susceptible to HIV-1 infection in vitro than were cells from healthy controls (P <.025, one-tailed Wilcoxon rank sum test). In contrast, the susceptibility to HIV-1 infection of lymphocytes from 6 seronegative hemophiliacs at moderate risk (50%-56%) of seroconversion did not differ from that of cells from controls or from high-risk hemophiliacs. Therefore, prolonged periods of seronegative HIV-1 infection are not common in this high-risk population. In addition, among hemophiliacs there may exist heterogeneity in susceptibility to HIV-1 infection in vitro and in vivo.

    Original languageEnglish (US)
    Pages (from-to)228-231
    Number of pages4
    JournalJournal of Infectious Diseases
    Volume172
    Issue number1
    DOIs
    Publication statusPublished - Jan 1 1995

      Fingerprint

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Infectious Diseases

    Cite this